Camel Antibodies Used to Fight Trypanosomes

Camel Antibodies Used to Fight TrypanosomesFigure 1Belgian scientists say that small antibodies taken from the dromedary may prove useful in treating tropical parasites such as the African trypanosome, which causes sleeping sickness. Penetrating the dense, variable-specific surface glycoproteins that coat the organism, such antibodies may be able to zero in on conserved oligosaccharides hidden beneath. Serge Muyl-dermans and colleagues at the University of Brussels demonstrated its use as a diag

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Belgian scientists say that small antibodies taken from the dromedary may prove useful in treating tropical parasites such as the African trypanosome, which causes sleeping sickness. Penetrating the dense, variable-specific surface glycoproteins that coat the organism, such antibodies may be able to zero in on conserved oligosaccharides hidden beneath. Serge Muyl-dermans and colleagues at the University of Brussels demonstrated its use as a diagnostic reagent for Trypanosoma brucei; by linking the antibody to an effector molecule, they showed that such an antibody could be used therapeutically. Muyldermans says that he thinks this holds great promise for the future.

Others who study tropical diseases doubt the wide applicability of such a technique. David Horn, lecturer at the London School of Hygiene and Tropical Medicine, writes in an E-mail, "The broad relevance of such reagents is questionable, since I'm not aware of other parasites with such dense surface coats that would provide ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies